Category: Latest News
-
Orion Energy Systems Preliminary FY26 Revenue and EBITDA Outlook Signals Improving Profitability Trend (OESX)
Orion reaffirmed Fiscal 2027 growth expectations as backlog expansion and enterprise customer demand continue to support momentum. Key Investor Takeaways Why OESX Stock Is In Focus Orion Energy Systems, Inc. (NASDAQ:OESX), which operates under the Orion Lighting brand, announced preliminary unaudited expectations for Fiscal Year 2026 revenue of $86 million and adjusted EBITDA of at…
-
Amesite shares skyrocket after landing largest enterprise client to date (AMST)
NurseMagic platform selected for large-scale healthcare deployment Amesite Inc. (NASDAQ:AMST) shares soared 190% in premarket trading Tuesday after the company announced it had secured its largest enterprise customer so far, covering approximately 2,700 patients. According to the company, the customer will implement the NurseMagic AI documentation platform across its workforce to improve workflow efficiency and…
-
T1 Energy shares fall after short seller raises regulatory compliance concerns (TE)
Stock declines after Fuzzy Panda Research discloses short position T1 Energy Inc. (NYSE:TE) shares dropped more than 4.4% in premarket trading Tuesday after short seller Fuzzy Panda Research announced it had taken a short position in the company. Fuzzy Panda published a report alleging that T1 Energy is not compliant with Foreign Entity of Concern…
-
Software stocks extend rebound as ServiceNow and Salesforce move higher
Investors return to software sector after prolonged weakness U.S. software stocks continued to recover in premarket trading on Tuesday, adding to recent gains as investors reassess the outlook for enterprise software companies following months of pressure on the sector. Concerns had grown in recent months that artificial intelligence could weaken the business models of traditional…
-
MakeMyTrip shares slide after revenue misses expectations despite earnings beat (MMYT)
Quarterly revenue falls short as travel disruptions weigh on growth MakeMyTrip Limited (NASDAQ:MMYT) reported mixed fourth-quarter fiscal 2026 results on Tuesday, with earnings surpassing analyst expectations while revenue came in below forecasts. Shares of the online travel platform dropped 6.2% in premarket trading following the release. The company posted adjusted earnings of $0.32 per share,…
-
Radcom shares decline despite earnings beat and solid revenue growth (RDCM)
Revenue misses expectations as shares move lower RADCOM Ltd. (NASDAQ:RDCM) reported mixed first-quarter results on Tuesday, with adjusted earnings coming in ahead of analyst forecasts while revenue slightly missed expectations. Shares of the intelligent network assurance solutions provider fell 4.29% in premarket trading following the release. The company posted adjusted earnings of $0.28 per share…
-
Antalpha shares rise despite earnings miss and weak second-quarter outlook (ANTA)
Revenue growth and profitability improvements support shares Antalpha Platform Holding Company (NASDAQ:ANTA) reported first-quarter results on Tuesday that fell short of analyst expectations, while also issuing second-quarter guidance well below market forecasts. Despite the weaker outlook, shares of the digital asset infrastructure platform rose 3.34% in premarket trading following the announcement. The company posted adjusted…
-
Eltek shares drop after first-quarter loss and revenue decline (ELTK)
Currency pressures and softer sales weigh on quarterly results Eltek Ltd. (NASDAQ:ELTK) shares fell 6.8% in premarket trading Tuesday after the printed circuit board manufacturer reported a first-quarter loss alongside weaker revenue and unfavorable currency movements. For the quarter ended March 31, 2026, the company posted a net loss of $2.9 million, or $0.42 per…
-
Relay Therapeutics shares jump after positive vascular anomalies trial results (RLAY)
Early Phase 2 data highlight promising efficacy and safety profile Relay Therapeutics Inc. (NASDAQ:RLAY) shares climbed 15% on Tuesday after the company released initial clinical results from its Phase 2 ReInspire study, showing that zovegalisib demonstrated encouraging safety and efficacy in patients with PIK3CA-driven vascular anomalies. The company reported a 60% volumetric response rate across…
-
Gilat shares rise after Boeing selects Sidewinder antenna for in-flight connectivity program (GILT)
Boeing partnership supports rollout of integrated airline connectivity systems Gilat Satellite Networks Ltd. (NASDAQ:GILT) shares gained 4% in premarket trading Tuesday after the company announced a new agreement with Boeing to provide its Sidewinder antenna as a line-fit option for in-flight connectivity providers. Under the partnership, Boeing will make Gilat’s multi-orbit Sidewinder electronically steered antenna…